Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-20 Purchase |
2021-12-22 6:21 pm |
Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director |
63,850 | $10.18 | $649,993 | 4,056,907 (Indirect) |
View |
| 2021-03-23 Purchase |
2021-03-25 6:05 pm |
Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director |
882,351 | $17 | $14,999,967 | 882,351 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-08 Option Award |
2023-06-09 4:16 pm |
N/A 2033-06-07 |
Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 5:01 pm |
N/A 2032-06-12 |
Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director |
44,843 | $0 | 44,843 (Direct) |
View |
| 2021-03-23 Conversion |
2021-03-25 6:05 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director |
3,110,706 | $0 | 882,351 (Indirect) |
View |
Ownership |
2021-03-18 9:18 pm |
N/A N/A |
Finch Therapeutics Group Inc. | FNCH | Haft Nicholas Director |
0 | $0 | 3,110,706 (Indirect) |
View |